286 results on '"Aman, Jurjan"'
Search Results
2. Mechanical stimulation of induced pluripotent stem cell derived cardiac fibroblasts
3. Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial
4. Clinical Correlates of a Nonplexiform Vasculopathy in Patients With a Diagnosis of Idiopathic Pulmonary Arterial Hypertension
5. The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS
6. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
7. SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension
8. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
9. Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.
10. Patients with CTEPH and mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulmonary endarterectomy compared to patients with severe hemodynamic disease
11. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
12. Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation
13. Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
14. Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model
15. Mechanical stimulation of induced pluripotent stem derived cardiac fibroblasts.
16. Correlation between Serum Biomarkers and Lung Ultrasound in COVID-19: An Observational Study.
17. CTEPH patients with mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulmonary endarterectomy compared to patients with severe hemodynamic disease.
18. Phenotyping of Pulmonary Oedema in COVID-19 ARDS
19. Plasma proteomics of critical COVID-19 patients and the effect of imatinib treatment
20. Empagliflozin improves mitochondrial biogenesis and ameliorates vascular remodeling in experimental pulmonary arterial hypertension
21. Biomarkers of alveolar epithelial injury and endothelial dysfunction are associated with scores of pulmonary edema in invasively ventilated patients
22. Correction to: Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation
23. Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
24. Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19
25. The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS
26. Integrin-Dependent Cell–Matrix Adhesion in Endothelial Health and Disease
27. Identification of New Drugs to Counteract Anti-Spike IgG-Induced Hyperinflammation in Severe COVID-19
28. Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPKα2
29. Tyrosine Kinases and Endothelial Homeostasis in Pulmonary Arterial Hypertension: Too Hot to Handle?
30. ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension
31. TheSOX17phenotype in pulmonary arterial hypertension: lessons for pathobiology and clinical management
32. Regulation of VWF (Von Willebrand Factor) in Inflammatory Thrombosis
33. Riociguat inhibits ultra‐large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients
34. Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
35. Pulmonary hypertension with warm hands
36. A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension
37. Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension
38. Long-term clinical outcomes of COVID-19 patients treated with imatinib
39. A modified perfusion protocol for pulmonary endarterectomy in a patient with a hematologic malignancy treated with a tyrosine kinase inhibitor.
40. Neutrophil Elastase: Finding Its Way From Mechanism, via Biomarker to Treatment Target in Pulmonary Hypertension?
41. SOX17Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension
42. A modified perfusion protocol for pulmonary endarterectomy in a patient with a hematologic malignancy treated with a tyrosine kinase inhibitor
43. Abstract 6931: Epigenetic Modification of the Von Willebrand Factor Promotor Drives in situ Thrombosis in Chronic Thromboembolic Pulmonary Hypertension
44. Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study
45. Neutrophil Elastase
46. Riociguat inhibits ultra-large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients.
47. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: A prospective sequential cohort study
48. Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19
49. Correction to: Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation
50. Effects of imatinib on vascular insulin sensitivity and free fatty acid transport in early weight gain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.